ANI Pharmaceuticals
ANIP
#4819
Rank
A$2.76 B
Marketcap
A$123.10
Share price
-1.17%
Change (1 day)
38.29%
Change (1 year)

ANI Pharmaceuticals (ANIP) - Total debt

Total debt on the balance sheet as of September 2025 : A$0.93 Billion

According to ANI Pharmaceuticals's latest financial reports the company's total debt is A$0.93 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ANI Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$1.00 B139.29%
2023-12-31A$0.41 B-0.41%
2022-12-31A$0.42 B6.22%
2021-12-31A$0.39 B64.14%
2020-12-31A$0.24 B-8.98%
2019-12-31A$0.26 B2.12%
2018-12-31A$0.25 B0.65%
2017-12-31A$0.25 B54.22%
2016-12-31A$0.16 B7.49%
2015-12-31A$0.15 B19.6%
2014-12-31A$0.13 B
2013-12-31N/A-100%
2012-12-31A$7.58 M-55.13%
2011-12-31A$16.9 M-7.4%
2010-12-31A$18.25 M-1.64%
2009-12-31A$18.56 M
2000-12-31A$0.89 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Jazz Pharmaceuticals
JAZZ
A$8.17 B 775.13%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
A$7.72 M-99.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$25.70 B 2,652.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
A$91.60 B 9,709.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
A$0.96 B 3.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$3.94 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
A$13.59 B 1,356.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$48.20 B 5,062.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
A$13.46 B 1,342.14%๐Ÿ‡ฌ๐Ÿ‡ง UK